ProPhase Labs Competitors and Similar CompaniesClear all
ProPhase Labs's competitors and similar companies include Delta-Fly Pharma, Nitrase Therapeutics and MigVax.
 ProPhase Labs ProPhase Labs develops and markets clinically proven remedies including the highly effective Cold-EEZE and Kids-EEZE product lines. |  Delta-Fly Pharma Delta-Fly Pharma 株式会社（デルタフライファーマ is a manufacturer and seller of anti-cancer agents and other products. |  Nitrase Therapeutics Nitrase Therapeutics is a biotech company intended to develop drugs against a new class of enzymes targeting Parkinson's disease. | ||
Founding Date | Founding Date 1981 | Founding Date 2010 | Founding Date 2012 | Founding Date N/A |
Type | Type Public | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations Doylestown, US HQ Old Bridge, US Uniondale, US | Locations HQ | Locations Brisbane, US HQ | Locations Qiryat Shemona, IL HQ |
Employees | Employees 477% increase | Employees N/A | Employees N/A | Employees N/A |
Valuation ($) | Valuation ($) 42.9 m | Valuation ($) 29.5 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $4.3m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $3m (FY, 2025) | Cost of goods (¥1.6m) (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $1.4m (FY, 2025) | Gross profit ¥1.6m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($14.7m) (FY, 2025) | Net income (¥1.7b) (FY, 2025) | Net income N/A | Net income N/A |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 38m (about 6 years ago) | Latest funding round $ 12m (about 6 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 38.1m | Total funding raised $ 12m |
For sources of this data, please see the company profile
View Company Profiles
Delta-Fly Pharma
HQ
Delta-Fly Pharma 株式会社（デルタフライファーマ is a manufacturer and seller of anti-cancer agents and other products.
View companyNitrase Therapeutics
HQ
Brisbane, US
Nitrase Therapeutics is a biotech company intended to develop drugs against a new class of enzymes targeting Parkinson's disease.
View company